Targeting bromodomains: epigenetic readers of lysine acetylation
Top Cited Papers
- 22 April 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 13 (5), 337-356
- https://doi.org/10.1038/nrd4286
Abstract
Lysine acetylation is a key mechanism that regulates chromatin structure; aberrant acetylation levels have been linked to the development of several diseases. Acetyl-lysine modifications create docking sites for bromodomains, which are small interaction modules found on diverse proteins, some of which have a key role in the acetylation-dependent assembly of transcriptional regulator complexes. These complexes can then initiate transcriptional programmes that result in phenotypic changes. The recent discovery of potent and highly specific inhibitors for the BET (bromodomain and extra-terminal) family of bromodomains has stimulated intensive research activity in diverse therapeutic areas, particularly in oncology, where BET proteins regulate the expression of key oncogenes and anti-apoptotic proteins. In addition, targeting BET bromodomains could hold potential for the treatment of inflammation and viral infection. Here, we highlight recent progress in the development of bromodomain inhibitors, and their potential applications in drug discovery.Keywords
This publication has 170 references indexed in Scilit:
- Small-Molecule Inhibition of BRDT for Male ContraceptionCell, 2012
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain FamilyCell, 2012
- The first bromodomain of the testis-specific double bromodomain protein Brdt is required for chromocenter organization that is modulated by genetic backgroundDevelopmental Biology, 2011
- Bromodomains as therapeutic targetsExpert Reviews in Molecular Medicine, 2011
- 3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain LigandsJournal of Medicinal Chemistry, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- Catalytic activity of the proteasome fine-tunes Brg1-mediated chromatin remodeling to regulate the expression of inflammatory genesMolecular Immunology, 2009
- Control of Inducible Gene Expression by Signal-Dependent Transcriptional ElongationCell, 2009
- The multi-tasking P-TEFb complexCurrent Opinion in Cell Biology, 2008
- Chromatin Modifications and Their FunctionCell, 2007